Atish Mathur, MD
Interventional Cardiology · Mansfield, OHNPI 1588895064
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (53.7%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. Edwards Lifesciences accounts for 74.5% of it on its own, with 21 other manufacturers making up the rest. Among interventional cardiology clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 641 payments — averaging $453.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$216K
- Medtronic$67K
- Boston Scientific$3K
- Abbott$2K
- Abiomed$702
- AstraZeneca$326
- plus $1K from 16 others
What the payments were for
- Consulting fees$156,07854%
- Speaking & faculty fees$59,11620%
- Travel & lodging$60,94321%
- Food & beverage$14,4375%
- Education$2040%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 254 | $216,499 |
| Medtronic(2 entities) | 253 | $67,128 |
| Boston Scientific | 45 | $3,168 |
| Abbott | 20 | $1,698 |
| Abiomed | 14 | $702 |
| AstraZeneca | 15 | $326 |
| Biotronik Inc. | 14 | $311 |
| Shockwave Medical, Inc | 1 | $193 |
| Cardiac Dimensions, Inc. | 1 | $163 |
| Jenavalve Technology, Inc. | 1 | $112 |
| E.r. Squibb & Sons, L.L.C. | 6 | $99 |
| Inari Medical, Inc. | 2 | $89 |
| Novartis | 3 | $64 |
| Actelion Pharmaceuticals US, Inc. | 1 | $55 |
| Amgen | 4 | $55 |
| Philips North America LLC | 1 | $28 |
| Cardiovascular Systems Inc. | 1 | $21 |
| Pfizer | 1 | $15 |
| Chiesi USA, Inc. | 1 | $15 |
| Boehringer Ingelheim | 1 | $13 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $13 |
| Johnson & Johnson | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Edwards SAPIEN 3 Transcatheter Heart Valve$210,522
- COREVALVE EVOLUT R$60,269
- CoreValve Evolut$2,539
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$1,387
- Watchman$1,321
- SAPIEN 3 Ultra RESILIA$1,239
- AMPLATZER AMULET$880
- WATCHMAN Access System$417
- Impella$270
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$193
- PASCAL$164
- AVVIGO Guidance System$150
- GENERAL - THERAPIES$138
- PORTICO$136
- IntellaTip MiFi Filter Module$135
- AMPLATZER$132
- Mitra Clip system$129
- JenaValve Pericardial TAVR System$112
How this compares
$290,778 in reported general payments places this provider in the 95th percentile of 256 interventional cardiology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 112 | $118,629 |
| EntrestoSacubitril/Valsartan | 75 | $71,496 |
| FarxigaDapagliflozin Propanediol | 31 | $23,032 |
| BrilintaTicagrelor | 26 | $20,631 |
| JardianceEmpagliflozin | 16 | $17,403 |
| XareltoRivaroxaban | 19 | $16,756 |
| Metoprolol Succinate | 161 | $2,905 |
| Ranolazine ErRanolazine | 19 | $2,754 |
| ClopidogrelClopidogrel Bisulfate | 253 | $2,484 |
| Atorvastatin Calcium | 174 | $1,930 |
| Potassium Chloride | 44 | $864 |
| Metoprolol Tartrate | 109 | $596 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 43 | $468 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 31 | $447 |
| Bumetanide | 19 | $444 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $15 | $118,629112 claims |
| NovartisEntresto | $64 | $71,49675 claims |
| AstraZenecaFarxiga, Brilinta | $326 | $43,66457 claims |
| Boehringer IngelheimJardiance | $13 | $17,40316 claims |
| Johnson & JohnsonXarelto | $11 | $16,75619 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 256 interventional cardiology providers in Ohio.
Other interventional cardiology in Mansfield
- Yohannes BayissaMansfield$31K
- Gary AnselColumbus$3.3M
- John CheathamColumbus$1.4M
- Carlos Sanchez SotoColumbus$1.1M
- Steven YakubovColumbus$907K
- Timothy HenryCincinnati$605K
- Mitchell SilverColumbus$562K
- John PhillipsColumbus$410K
- John CorlCincinnati$390K
- Santiago GarciaCincinnati$360K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.